Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 9/20 | 0.71 |
| ▸ | GRIK2 | Q13002 | 6/20 | 0.71 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.71 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.71 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.42 |
| ▸ | GGT1 | P19440 | 4/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.41 |
| ▸ | GRIK3 | Q13003 | 3/20 | 0.41 |
| ▸ | GRIK5 | Q16478 | 3/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.40 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.39 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1331822 | 1.00 | GRIK1 (0.71) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| SCHEMBL497587 | 0.83 | GRIK1 (1.00) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| SCHEMBL3981383 | 0.83 | GRIK1 (1.00) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| SCHEMBL1476505 | 0.83 | GRIK1 (1.00) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Hydrochloric Acid SCHEMBL4186334 | 0.81 | GRIK1 (0.95) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Hydrochloric Acid SCHEMBL6235798 | 0.81 | GRIK1 (0.95) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Ammonia Solution, Strong SCHEMBL638403 | 0.81 | GRIK1 (0.95) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| SCHEMBL5797481 | 0.79 | GRIK1 (0.68) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Aspartic Acid SCHEMBL8159324 | 0.77 | GRIK1 (0.52) | GRIK1GRIK2GRM1GRM2SLC7A5 | |
| Aspartic Acid SCHEMBL8159323 | 0.77 | GRIK1 (0.52) | GRIK1GRIK2GRM1GRM2SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122030393-A | Plant salt-tolerant resistance inducer, screening method and application thereof | 南通大学 | 2026-05-15 | — | — | CN | claimed |
| US-9101662-B2 | Compositions with modulating agents | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-08-11 | — | — | US | claimed |
| US-8795693-B2 | Compositions with modulating agents | FOAMIX LTD. (IL) | 2014-08-05 | — | — | US | claimed |
| CN-101611195-A | Detoxifying pretreated lignocellulose-containing material | NOVOZYMES NORTH AMERICA INC (US) | 2009-12-23 | — | — | CN | claimed |
| EP-2097065-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | Foamix Ltd. (IL) | 2009-09-09 | — | — | EP | claimed |
| EP-1554235-B1 | PROCESS FOR SYNTHESIZING L-Y-METHYLENE GLUTAMIC ACID AND ANALOGS | BIONUMERIK PHARMACEUTICALS INC (US) | 2009-02-18 | — | — | EP | claimed |
| WO-2008152444-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | FOAMIX LTD. (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | FOAMIX LTD. (IL) | 2008-08-28 | — | — | US | claimed |
| EP-1373225-B1 | PROCESS FOR COUPLING AMINO ACIDS TO AN ANTIFOLATE SCAFFOLD | BIONUMERIK PHARMACEUTICALS INC (US) | 2006-05-24 | — | — | EP | claimed |
| WO-2004021981-A2 | METHODS FOR THE PREPARATION OF β-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-03-18 | — | — | WO | claimed |
| US-20030113882-A1 | Methods for the preparation of beta-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-06-19 | — | — | US | claimed |
| EP-0731648-B1 | FLAVOURING COMPOSITIONS AND METHOD | FIRMENICH & CIE (CH) | 2003-03-26 | — | — | EP | claimed |
| EP-0513068-B1 | THREE NEW NON-POLYGLUTAMATABLE DEAZAAMINOPTERINS AND PROCESS FOR PREPARING THE SAME | NAIR MADHAVAN G (US) | 1995-09-13 | — | — | EP | claimed |
| CN-122030393-A | Plant salt-tolerant resistance inducer, screening method and application thereof | 南通大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-122030393-A | Plant salt-tolerant resistance inducer, screening method and application thereof | 南通大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-121380418-A | SNP molecular marker related to cucumber and pseudomonas recruitment and application thereof | 中国农业科学院蔬菜花卉研究所 | 2026-01-23 | — | — | CN | disclosed |
| EP-1205773-A2 | Hydrogel contact lenses with improved biocompatibility | Wöhlk-Contact-Linsen GmbH (DE) | 2002-05-15 | — | — | EP | disclosed |
| EP-1185517-A1 | ANTIBIOTIC PRODRUGS | University of Massachusetts (US) | 2002-03-13 | — | — | EP | disclosed |
| WO-2000071523-A1 | ANTIBIOTIC PRODRUGS | UNIVERSITY OF MASSACHUSETTS (US) | 2000-11-30 | — | — | WO | disclosed |
| US-6031156-A | NUCLEOTIDE SEQUENCES; FOR TRANSGENIC PLANTS WITH DARKNESS AND ORGAN SPECIFIC GENE EXPRESSION | NEW YORK UNIVERSITY (US) | 2000-02-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | CUTA, SLTM, SMO | GRIK1 2104/4885GRIK2 2050/4885GRM1 3005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.